The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

6 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
The natural flavone fukugetin as a mixed-type inhibitor for human tissue kallikreins.EBI
Campus
Structural optimization, biological evaluation, and application of peptidomimetic prostate specific antigen inhibitors.EBI
The Johns Hopkins University
Kallikrein protease activated receptor (PAR) axis: an attractive target for drug development.EBI
Universit£
Human kallikrein 6 inhibitors with a para-amidobenzylanmine P1 group identified through virtual screening.EBI
Sanofi Pharmaceuticals
Phage-encoded combinatorial chemical libraries based on bicyclic peptides.EBI
Laboratory Of Molecular Biology, Medical Research Council
Optimization of peptide-based inhibitors of prostate-specific antigen (PSA) as targeted imaging agents for prostate cancer.EBI
The Johns Hopkins University School Of Medicine